0 XP   0   0   0

Roche Holding Ltd ADR
Buy or Sell?

Welcome Invester! I guess you are interested in Roche Holding Ltd ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's start. I'm going to help you getting a better view of Roche Holding Ltd ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Roche Holding Ltd ADR even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Roche Holding Ltd ADR is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Roche Holding Ltd ADR. The closing price on 2022-09-29 was $41.11 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Roche Holding Ltd ADR Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

1.1. Profitability of Roche Holding Ltd ADR.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Roche earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Roche to the Drug Manufacturers-General industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Roche Holding Ltd ADR:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y8.9%-8.9%
5Y8.9%10Y12.7%-3.8%
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.9%-12.9%
TTM-14.7%-14.7%
YOY-13.2%-13.2%
5Y8.9%13.0%-4.1%
10Y12.7%14.9%-2.2%
1.1.2. Return on Assets

Shows how efficient Roche is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Roche to the Drug Manufacturers-General industry mean.
  • 4.1% Return on Assets means that Roche generated $0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Roche Holding Ltd ADR:

  • The MRQ is 4.9%. Using its assets, the company is less efficient in making profit.
  • The TTM is 4.1%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.9%TTM4.1%+0.8%
TTM4.1%YOY4.1%0.0%
TTM4.1%5Y4.0%+0.0%
5Y4.0%10Y5.1%-1.0%
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ4.9%1.8%+3.1%
TTM4.1%2.3%+1.8%
YOY4.1%1.8%+2.3%
5Y4.0%2.0%+2.0%
10Y5.1%2.1%+3.0%
1.1.3. Return on Equity

Shows how efficient Roche is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Roche to the Drug Manufacturers-General industry mean.
  • 16.9% Return on Equity means the company generated $0.17 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Roche Holding Ltd ADR:

  • The MRQ is 16.9%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 13.7%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ16.9%TTM13.7%+3.2%
TTM13.7%YOY9.9%+3.9%
TTM13.7%5Y11.3%+2.4%
5Y11.3%10Y16.5%-5.1%
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ16.9%4.4%+12.5%
TTM13.7%4.9%+8.8%
YOY9.9%4.8%+5.1%
5Y11.3%4.6%+6.7%
10Y16.5%4.6%+11.9%

1.2. Operating Efficiency of Roche Holding Ltd ADR.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Roche is operating .

  • Measures how much profit Roche makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Roche to the Drug Manufacturers-General industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Roche Holding Ltd ADR:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y15.0%-15.0%
5Y15.0%10Y11.3%+3.7%
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.2%-17.2%
TTM-17.2%-17.2%
YOY-17.2%-17.2%
5Y15.0%18.2%-3.2%
10Y11.3%17.6%-6.3%
1.2.2. Operating Ratio

Measures how efficient Roche is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-General industry mean).
  • An Operation Ratio of 0.0% means that the operating costs are $0.00for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Roche Holding Ltd ADR:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.462-0.462
5Y0.46210Y0.409+0.054
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.091-1.091
TTM-1.020-1.020
YOY-0.950-0.950
5Y0.4620.960-0.498
10Y0.4090.869-0.460

1.3. Liquidity of Roche Holding Ltd ADR.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Roche is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-General industry mean).
  • A Current Ratio of 110.6% means the company has $1.11 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Roche Holding Ltd ADR:

  • The MRQ is 1.106. The company is just able to pay all its short-term debts.
  • The TTM is 1.017. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.106TTM1.017+0.089
TTM1.017YOY1.269-0.252
TTM1.0175Y1.257-0.240
5Y1.25710Y0.893+0.364
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1061.432-0.326
TTM1.0171.398-0.381
YOY1.2691.420-0.151
5Y1.2571.392-0.135
10Y0.8931.381-0.488
1.3.2. Quick Ratio

Measures if Roche is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Drug Manufacturers-General industry mean)
  • A Quick Ratio of 49.5% means the company can pay off $0.50 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Roche Holding Ltd ADR:

  • The MRQ is 0.495. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.429. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.495TTM0.429+0.066
TTM0.429YOY0.560-0.130
TTM0.4295Y0.604-0.174
5Y0.60410Y0.516+0.088
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4950.849-0.354
TTM0.4290.810-0.381
YOY0.5600.788-0.228
5Y0.6040.851-0.247
10Y0.5160.765-0.249

1.4. Solvency of Roche Holding Ltd ADR.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Roche assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Drug Manufacturers-General industry mean).
  • A Debt to Asset Ratio of 0.67 means that Roche assets are financed with 66.6% credit (debt) and the remaining percentage (100% - 66.6%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Roche Holding Ltd ADR:

  • The MRQ is 0.666. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.645. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.666TTM0.645+0.021
TTM0.645YOY0.543+0.102
TTM0.6455Y0.597+0.048
5Y0.59710Y0.631-0.034
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6660.487+0.179
TTM0.6450.503+0.142
YOY0.5430.540+0.003
5Y0.5970.525+0.072
10Y0.6310.517+0.114
1.4.2. Debt to Equity Ratio

Measures if Roche is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Drug Manufacturers-General industry mean).
  • A Debt to Equity ratio of 229.4% means that company has $2.29 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Roche Holding Ltd ADR:

  • The MRQ is 2.294. The company is just not able to pay all its debts with equity.
  • The TTM is 2.187. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.294TTM2.187+0.107
TTM2.187YOY1.306+0.880
TTM2.1875Y1.693+0.494
5Y1.69310Y2.003-0.310
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2940.952+1.342
TTM2.1871.033+1.154
YOY1.3061.157+0.149
5Y1.6931.140+0.553
10Y2.0031.089+0.914

2. Market Valuation of Roche Holding Ltd ADR

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in Roche.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of 2.38 means the investor is paying $2.38 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Roche Holding Ltd ADR:

  • The EOD is 2.350. Very good. +2
  • The MRQ is 2.384. Very good. +2
  • The TTM is 2.821. Very good. +2
Trends
Current periodCompared to+/- 
EOD2.350MRQ2.384-0.034
MRQ2.384TTM2.821-0.437
TTM2.821YOY2.654+0.167
TTM2.8215Y2.651+0.170
5Y2.65110Y2.903-0.252
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
EOD2.35014.897-12.547
MRQ2.38417.928-15.544
TTM2.82119.640-16.819
YOY2.65421.657-19.003
5Y2.65121.014-18.363
10Y2.90320.535-17.632
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Roche.

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of Roche Holding Ltd ADR:

  • The MRQ is 0.365. Very good. +2
  • The TTM is 0.827. Good. +1
Trends
Current periodCompared to+/- 
MRQ0.365TTM0.827-0.462
TTM0.827YOY1.761-0.933
TTM0.8275Y0.686+0.142
5Y0.68610Y0.860-0.175
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3650.086+0.279
TTM0.8270.002+0.825
YOY1.761-0.076+1.837
5Y0.686-0.048+0.734
10Y0.8600.003+0.857

2. Books
2.3. Price to Book Ratio

Measures if the stock price of Roche is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-General industry mean).
  • A PB ratio of 1.15 means the investor is paying $1.15 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Roche Holding Ltd ADR:

  • The EOD is 1.137. Good. +1
  • The MRQ is 1.154. Good. +1
  • The TTM is 1.285. Good. +1
Trends
Current periodCompared to+/- 
EOD1.137MRQ1.154-0.017
MRQ1.154TTM1.285-0.131
TTM1.285YOY0.958+0.327
TTM1.2855Y0.599+0.686
5Y0.59910Y0.386+0.212
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
EOD1.1372.884-1.747
MRQ1.1543.222-2.068
TTM1.2853.587-2.302
YOY0.9583.578-2.620
5Y0.5993.166-2.567
10Y0.3863.020-2.634

2.4. Latest News of Roche Holding Ltd ADR

Does Roche Holding Ltd ADR still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Roche Holding Ltd ADR to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2022-09-26
07:25
Change in the Roche Board of DirectorsRead
2022-09-19
07:00
European Commission approves Roche’s Vabysmo, the first bispecific antibody for the eye, for two leading causes of vision lossRead
2022-09-09
21:58
Regeneron's Eylea Win Leaves an Elephant in the RoomRead

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Roche Holding Ltd ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Gains Per Share--2.976-3.086+204%1.941+53%3.287-9%3.287-9%
Book Value Per Share--36.15637.755-4%45.620-21%22.903+58%14.776+145%
Current Ratio--1.1061.017+9%1.269-13%1.257-12%0.893+24%
Debt To Asset Ratio--0.6660.645+3%0.543+23%0.597+12%0.631+6%
Debt To Equity Ratio--2.2942.187+5%1.306+76%1.693+36%2.003+15%
Dividend Per Share--4.7924.566+5%4.552+5%4.134+16%4.134+16%
Eps--5.3274.373+22%4.105+30%3.824+39%3.511+52%
Gains Per Share--7.7671.479+425%6.493+20%7.421+5%7.421+5%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin----0%-0%0.089-100%0.127-100%
Operating Margin----0%-0%0.150-100%0.113-100%
Operating Ratio----0%-0%0.462-100%0.409-100%
Pb Ratio1.137-1%1.1541.285-10%0.958+20%0.599+93%0.386+199%
Pe Ratio2.350-1%2.3842.821-15%2.654-10%2.651-10%2.903-18%
Peg Ratio--0.3650.827-56%1.761-79%0.686-47%0.860-58%
Price Per Share41.110-1%41.71047.070-11%43.550-4%38.705+8%39.445+6%
Quick Ratio--0.4950.429+15%0.560-12%0.604-18%0.516-4%
Return On Assets--0.0490.041+20%0.041+20%0.040+22%0.051-3%
Return On Equity--0.1690.137+23%0.099+72%0.113+50%0.165+3%
 EOD+3 -0MRQTTM+12 -3YOY+9 -65Y+9 -910Y+9 -9

3.2. Fundamental Score

Let's check the fundamental score of Roche Holding Ltd ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-152.350
Price to Book Ratio (EOD)Between0-11.137
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.495
Current Ratio (MRQ)Greater than11.106
Debt to Asset Ratio (MRQ)Less than10.666
Debt to Equity Ratio (MRQ)Less than12.294
Return on Equity (MRQ)Greater than0.150.169
Return on Assets (MRQ)Greater than0.050.049
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Roche Holding Ltd ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.795
Ma 20Greater thanMa 5041.057
Ma 50Greater thanMa 10041.378
Ma 100Greater thanMa 20041.294
OpenGreater thanClose40.980
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in CHF. All numbers in thousands.

Summary
Total Assets86,736,000
Total Liabilities57,790,000
Total Stockholder Equity25,189,000
 As reported
Total Liabilities 57,790,000
Total Stockholder Equity+ 25,189,000
Total Assets = 86,736,000

Assets

Total Assets86,736,000
Total Current Assets30,321,000
Long-term Assets30,321,000
Total Current Assets
Cash And Cash Equivalents 4,315,000
Short-term Investments 2,493,000
Net Receivables 11,078,000
Inventory 8,292,000
Other Current Assets 4,143,000
Total Current Assets  (as reported)30,321,000
Total Current Assets  (calculated)30,321,000
+/-0
Long-term Assets
Property Plant Equipment 24,324,000
Goodwill 11,160,000
Intangible Assets 11,735,000
Other Assets 9,196,000
Long-term Assets  (as reported)56,415,000
Long-term Assets  (calculated)56,415,000
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities27,409,000
Long-term Liabilities30,381,000
Total Stockholder Equity25,189,000
Total Current Liabilities
Short Long Term Debt 5,381,000
Accounts payable 3,896,000
Other Current Liabilities 18,132,000
Total Current Liabilities  (as reported)27,409,000
Total Current Liabilities  (calculated)27,409,000
+/-0
Long-term Liabilities
Long term Debt 22,369,000
Other Liabilities 6,665,000
Long-term Liabilities Other 1,347,000
Long-term Liabilities  (as reported)30,381,000
Long-term Liabilities  (calculated)30,381,000
+/-0
Total Stockholder Equity
Common Stock25,189,000
Total Stockholder Equity (as reported)25,189,000
Total Stockholder Equity (calculated)25,189,000
+/-0
Other
Capital Stock107,000
Common Stock Shares Outstanding 800,579
Net Debt 23,435,000
Net Invested Capital 52,939,000
Net Tangible Assets 2,294,000
Net Working Capital 2,912,000



Balance Sheet

Currency in CHF. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-06-302015-12-312015-06-302014-12-312014-06-302013-12-312013-06-302012-12-312012-06-302011-12-312011-06-302010-12-312010-06-302009-12-312009-06-302008-12-312008-06-302007-12-312007-06-302006-12-312006-06-302005-12-312005-06-302004-12-312004-06-302003-12-312003-06-302002-12-312002-06-302001-12-312001-06-302000-12-312000-06-30
> Total Assets 
42,467,597
42,917,002
41,734,751
45,358,477
44,609,920
46,262,561
44,501,073
48,050,081
46,367,412
50,890,291
48,918,717
52,757,073
53,027,208
61,020,090
62,364,706
69,011,387
69,292,296
71,291,108
70,520,843
71,987,835
59,264,897
65,129,683
65,729,229
65,688,073
62,843,437
70,786,455
62,871,958
69,819,182
69,878,214
76,143,547
73,718,168
75,634,421
76,096,814
75,609,252
71,848,000
74,951,000
76,676,000
78,739,000
81,824,367
78,678,543
79,809,921
79,988,794
81,170,782
80,194,000
84,941,129
83,091,000
0
80,363,000
0
86,138,000
0
87,887,000
0
92,317,000
0
86,736,000
86,736,000092,317,000087,887,000086,138,000080,363,000083,091,00084,941,12980,194,00081,170,78279,988,79479,809,92178,678,54381,824,36778,739,00076,676,00074,951,00071,848,00075,609,25276,096,81475,634,42173,718,16876,143,54769,878,21469,819,18262,871,95870,786,45562,843,43765,688,07365,729,22965,129,68359,264,89771,987,83570,520,84371,291,10869,292,29669,011,38762,364,70661,020,09053,027,20852,757,07348,918,71750,890,29146,367,41248,050,08144,501,07346,262,56144,609,92045,358,47741,734,75142,917,00242,467,597
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
26,672,000
26,672,000
31,572,000
31,572,000
30,977,601
29,786,634
32,774,954
32,848,411
32,708,605
32,315,000
31,254,000
31,254,000
27,703,000
27,703,000
32,942,000
32,942,000
31,260,000
31,260,000
35,627,000
35,627,000
30,321,000
30,321,000
30,321,00030,321,00035,627,00035,627,00031,260,00031,260,00032,942,00032,942,00027,703,00027,703,00031,254,00031,254,00032,315,00032,708,60532,848,41132,774,95429,786,63430,977,60131,572,00031,572,00026,672,00026,672,0000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,878,439
2,357,598
1,836,829
1,964,991
2,436,705
4,111,372
4,328,940
4,948,116
3,773,545
4,492,363
4,688,769
3,766,861
3,474,214
3,724,668
2,876,838
4,097,441
3,453,000
3,602,000
4,719,000
4,846,000
5,540,088
5,327,093
6,791,014
6,806,235
5,758,293
5,689,000
6,210,268
6,075,000
0
3,770,000
0
5,727,000
0
5,000,000
0
6,850,000
0
4,315,000
4,315,00006,850,00005,000,00005,727,00003,770,00006,075,0006,210,2685,689,0005,758,2936,806,2356,791,0145,327,0935,540,0884,846,0004,719,0003,602,0003,453,0004,097,4412,876,8383,724,6683,474,2143,766,8614,688,7694,492,3633,773,5454,948,1164,328,9404,111,3722,436,7051,964,9911,836,8292,357,5982,878,439000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,899,236
15,551,264
6,442,362
9,670,189
7,387,377
7,929,379
5,391,671
10,334,244
4,439,153
8,911,725
6,902,346
8,017,918
3,801,626
5,430,768
3,803,105
4,874,016
3,482,000
3,632,000
7,278,000
7,474,000
3,862,257
3,713,768
2,218,947
2,223,920
5,549,784
5,483,000
3,549,309
5,783,000
0
2,482,000
0
6,607,000
0
3,017,000
0
6,181,000
0
2,493,000
2,493,00006,181,00003,017,00006,607,00002,482,00005,783,0003,549,3095,483,0005,549,7842,223,9202,218,9473,713,7683,862,2577,474,0007,278,0003,632,0003,482,0004,874,0163,803,1055,430,7683,801,6268,017,9186,902,3468,911,7254,439,15310,334,2445,391,6717,929,3797,387,3779,670,1896,442,36215,551,26414,899,236000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,526,000
9,526,000
11,287,000
11,287,000
11,205,778
10,774,960
11,588,738
11,614,711
12,096,566
11,760,000
11,964,000
11,964,000
11,855,000
11,855,000
11,699,000
11,699,000
11,809,000
11,809,000
12,628,000
12,628,000
11,078,000
11,078,000
11,078,00011,078,00012,628,00012,628,00011,809,00011,809,00011,699,00011,699,00011,855,00011,855,00011,964,00011,964,00011,760,00012,096,56611,614,71111,588,73810,774,96011,205,77811,287,00011,287,0009,526,0009,526,0000000000000000000000000000000000000
       Inventory 
0
3,551,369
0
3,482,348
3,658,177
4,137,931
4,526,222
4,058,966
4,051,917
4,008,062
3,844,237
3,834,043
4,105,403
4,585,486
5,105,283
5,395,887
5,785,140
5,462,382
5,454,127
5,452,790
5,193,057
5,306,863
5,529,538
5,397,909
5,812,335
6,053,523
6,219,048
6,632,974
7,280,108
7,794,443
7,878,237
7,635,020
8,395,629
7,803,150
7,717,000
8,050,000
7,407,000
7,606,000
7,659,619
7,365,137
6,730,026
6,745,110
6,654,073
6,574,000
6,055,000
6,055,000
6,787,000
6,787,000
7,194,000
7,194,000
8,319,000
8,319,000
7,715,000
7,715,000
8,292,000
8,292,000
8,292,0008,292,0007,715,0007,715,0008,319,0008,319,0007,194,0007,194,0006,787,0006,787,0006,055,0006,055,0006,574,0006,654,0736,745,1106,730,0267,365,1377,659,6197,606,0007,407,0008,050,0007,717,0007,803,1508,395,6297,635,0207,878,2377,794,4437,280,1086,632,9746,219,0486,053,5235,812,3355,397,9095,529,5385,306,8635,193,0575,452,7905,454,1275,462,3825,785,1405,395,8875,105,2834,585,4864,105,4033,834,0433,844,2374,008,0624,051,9174,058,9664,526,2224,137,9313,658,1773,482,34803,551,3690
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
47,879,000
0
51,837,000
0
52,660,000
0
53,196,000
0
56,627,000
0
56,690,000
0
56,415,000
56,415,000056,690,000056,627,000053,196,000052,660,000051,837,000047,879,0000000000000000000000000000000000000000000000
       Property Plant Equipment 
8,258,858
8,508,102
7,896,817
9,068,561
9,469,169
9,711,560
9,977,810
10,092,084
10,174,919
10,872,766
10,951,905
11,482,355
11,920,168
13,462,075
14,164,066
15,740,136
17,212,311
17,043,006
16,213,306
17,085,345
16,522,183
17,855,694
18,049,448
17,282,910
16,616,764
16,823,593
16,300,529
17,699,910
18,053,675
17,309,241
17,650,332
18,441,649
19,495,507
19,642,717
19,798,000
20,653,000
20,912,000
21,476,000
22,221,059
21,366,747
22,177,272
22,226,976
23,163,000
23,163,000
23,318,000
23,318,000
23,247,000
23,247,000
23,270,000
23,270,000
24,300,000
24,300,000
24,412,000
24,412,000
24,324,000
24,324,000
24,324,00024,324,00024,412,00024,412,00024,300,00024,300,00023,270,00023,270,00023,247,00023,247,00023,318,00023,318,00023,163,00023,163,00022,226,97622,177,27221,366,74722,221,05921,476,00020,912,00020,653,00019,798,00019,642,71719,495,50718,441,64917,650,33217,309,24118,053,67517,699,91016,300,52916,823,59316,616,76417,282,91018,049,44817,855,69416,522,18317,085,34516,213,30617,043,00617,212,31115,740,13614,164,06613,462,07511,920,16811,482,35510,951,90510,872,76610,174,91910,092,0849,977,8109,711,5609,469,1699,068,5617,896,8178,508,1028,258,858
       Goodwill 
0
0
0
3,679,359
0
3,660,811
4,235,520
4,205,170
5,015,176
4,847,529
4,648,791
4,663,827
4,616,824
4,849,528
5,387,734
6,033,189
7,927,857
7,826,291
7,865,096
7,975,477
7,831,818
8,242,075
8,459,528
8,366,759
8,199,263
8,170,399
8,079,366
8,024,483
8,184,484
10,015,100
10,885,941
11,063,193
11,264,297
11,104,330
10,768,000
11,233,000
10,077,000
10,348,000
12,091,271
11,626,409
9,095,345
9,115,729
8,986,136
8,878,000
12,733,349
12,456,000
0
10,109,000
0
9,249,000
0
10,623,000
0
10,809,000
0
11,160,000
11,160,000010,809,000010,623,00009,249,000010,109,000012,456,00012,733,3498,878,0008,986,1369,115,7299,095,34511,626,40912,091,27110,348,00010,077,00011,233,00010,768,00011,104,33011,264,29711,063,19310,885,94110,015,1008,184,4848,024,4838,079,3668,170,3998,199,2638,366,7598,459,5288,242,0757,831,8187,975,4777,865,0967,826,2917,927,8576,033,1895,387,7344,849,5284,616,8244,663,8274,648,7914,847,5295,015,1764,205,1704,235,5203,660,81103,679,359000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
582,000
582,000
0
0
611,913
613,284
0
0
755,455
1,056,855
0
0
0
0
0
0
0
0
0
0
00000000001,056,855755,45500613,284611,91300582,000582,000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
9,002,892
8,784,182
9,289,380
9,994,082
9,815,024
10,771,566
10,403,085
9,589,934
9,421,965
9,026,273
9,334,153
10,077,887
11,634,743
14,856,892
14,498,267
14,174,105
13,772,928
13,315,390
13,720,781
13,923,691
13,835,075
13,071,166
12,773,348
12,262,435
12,453,953
12,625,170
22,981,679
24,848,063
24,900,669
24,414,828
22,960,629
9,422,000
21,062,000
8,368,000
18,941,000
10,957,714
10,536,433
9,499,898
9,521,190
9,188,572
9,078,000
8,544,102
8,358,000
0
11,394,000
0
12,017,000
0
12,510,000
0
12,117,000
0
11,735,000
11,735,000012,117,000012,510,000012,017,000011,394,00008,358,0008,544,1029,078,0009,188,5729,521,1909,499,89810,536,43310,957,71418,941,0008,368,00021,062,0009,422,00022,960,62924,414,82824,900,66924,848,06322,981,67912,625,17012,453,95312,262,43512,773,34813,071,16613,835,07513,923,69113,720,78113,315,39013,772,92814,174,10514,498,26714,856,89211,634,74310,077,8879,334,1539,026,2739,421,9659,589,93410,403,08510,771,5669,815,0249,994,0829,289,3808,784,1829,002,892000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,305,000
0
451,000
0
1,939,000
0
617,000
0
2,199,000
0
834,000
0
2,046,000
2,046,0000834,00002,199,0000617,00001,939,0000451,00001,305,0000000000000000000000000000000000000000000000
> Total Liabilities 
23,561,289
23,144,382
21,836,041
24,954,211
23,958,446
27,631,028
24,826,541
24,492,730
21,284,344
21,716,614
18,644,279
21,008,519
20,657,987
22,632,226
21,287,205
21,957,808
21,089,983
20,862,925
65,596,761
62,899,208
52,024,317
52,682,250
52,837,276
50,238,958
50,111,755
52,514,472
45,862,434
45,963,611
47,907,082
54,442,319
53,155,361
52,373,964
54,568,015
49,623,032
46,569,000
48,580,000
47,669,000
48,952,000
50,261,671
48,329,308
48,943,891
49,053,586
49,777,000
49,178,000
48,275,504
47,224,000
0
45,548,000
0
46,365,000
0
46,454,000
0
63,972,000
0
57,790,000
57,790,000063,972,000046,454,000046,365,000045,548,000047,224,00048,275,50449,178,00049,777,00049,053,58648,943,89148,329,30850,261,67148,952,00047,669,00048,580,00046,569,00049,623,03254,568,01552,373,96453,155,36154,442,31947,907,08245,963,61145,862,43452,514,47250,111,75550,238,95852,837,27652,682,25052,024,31762,899,20865,596,76120,862,92521,089,98321,957,80821,287,20522,632,22620,657,98721,008,51918,644,27921,716,61421,284,34424,492,73024,826,54127,631,02823,958,44624,954,21121,836,04123,144,38223,561,289
   > Total Current Liabilities 
8,273,670
8,552,540
8,349,844
9,427,039
8,504,021
11,112,557
10,797,396
9,421,648
8,059,105
8,675,955
6,193,970
7,219,349
6,904,966
10,407,544
9,922,416
12,758,408
11,312,488
11,340,766
24,464,894
21,304,306
16,353,258
15,986,765
18,280,043
17,292,511
18,980,496
22,074,276
17,147,090
17,699,910
20,172,530
23,261,526
23,220,629
23,727,663
24,975,490
22,244,094
20,607,000
21,497,000
22,160,000
22,756,000
24,113,460
23,186,393
23,412,279
23,464,751
23,731,578
23,446,000
24,119,000
24,119,000
22,463,000
22,463,000
25,401,000
25,401,000
25,193,000
25,193,000
38,416,000
38,416,000
27,409,000
27,409,000
27,409,00027,409,00038,416,00038,416,00025,193,00025,193,00025,401,00025,401,00022,463,00022,463,00024,119,00024,119,00023,446,00023,731,57823,464,75123,412,27923,186,39324,113,46022,756,00022,160,00021,497,00020,607,00022,244,09424,975,49023,727,66323,220,62923,261,52620,172,53017,699,91017,147,09022,074,27618,980,49617,292,51118,280,04315,986,76516,353,25821,304,30624,464,89411,340,76611,312,48812,758,4089,922,41610,407,5446,904,9667,219,3496,193,9708,675,9558,059,1059,421,64810,797,39611,112,5578,504,0219,427,0398,349,8448,552,5408,273,670
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21,115,000
21,115,000
2,364,000
2,364,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000002,364,0002,364,00021,115,00021,115,0000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21,115,000
21,115,000
2,364,000
2,364,000
1,391,040
1,337,560
2,170,157
2,175,020
2,911,030
4,173,000
295,435
1,695,000
0
2,552,000
0
3,996,000
0
3,726,000
0
15,122,000
0
5,381,000
5,381,000015,122,00003,726,00003,996,00002,552,00001,695,000295,4354,173,0002,911,0302,175,0202,170,1571,337,5601,391,0402,364,0002,364,00021,115,00021,115,0000000000000000000000000000000000000
       Accounts payable 
0
1,367,098
0
1,030,245
1,111,930
787,971
1,359,568
693,861
1,405,751
810,550
1,274,656
1,042,744
1,537,382
1,147,191
1,732,149
1,048,636
1,914,331
986,602
1,763,136
1,254,103
1,705,959
1,217,846
1,975,514
1,294,005
1,711,123
1,236,483
1,960,847
1,738,544
2,355,661
2,161,264
2,451,316
2,444,844
2,547,998
2,646,654
2,691,000
2,807,000
3,034,000
2,861,000
3,027,004
2,910,628
2,893,881
2,900,367
3,289,586
3,250,000
3,391,000
3,391,000
3,042,000
3,042,000
3,317,000
3,317,000
4,241,000
4,241,000
4,115,000
4,115,000
3,896,000
3,896,000
3,896,0003,896,0004,115,0004,115,0004,241,0004,241,0003,317,0003,317,0003,042,0003,042,0003,391,0003,391,0003,250,0003,289,5862,900,3672,893,8812,910,6283,027,0042,861,0003,034,0002,807,0002,691,0002,646,6542,547,9982,444,8442,451,3162,161,2642,355,6611,738,5441,960,8471,236,4831,711,1231,294,0051,975,5141,217,8461,705,9591,254,1031,763,136986,6021,914,3311,048,6361,732,1491,147,1911,537,3821,042,7441,274,656810,5501,405,751693,8611,359,568787,9711,111,9301,030,24501,367,0980
       Other Current Liabilities 
5,079,620
3,276,715
4,952,137
3,546,210
3,250,000
4,182,029
3,288,705
4,406,301
3,142,172
5,271,644
3,929,214
5,569,669
4,403,992
5,916,359
4,946,557
7,078,296
5,802,783
7,252,881
10,311,954
11,601,661
10,019,491
10,245,491
9,305,837
10,024,535
9,153,400
11,072,638
9,010,582
11,440,925
10,192,827
12,057,580
10,367,002
12,365,977
10,446,283
11,648,621
13,532,000
10,304,000
5,817,000
13,190,000
16,120,996
15,501,208
10,910,754
10,935,208
16,035,972
9,929,000
7,418,000
7,418,000
16,830,000
16,830,000
9,895,000
9,895,000
17,226,000
17,226,000
9,737,000
9,737,000
18,132,000
18,132,000
18,132,00018,132,0009,737,0009,737,00017,226,00017,226,0009,895,0009,895,00016,830,00016,830,0007,418,0007,418,0009,929,00016,035,97210,935,20810,910,75415,501,20816,120,99613,190,0005,817,00010,304,00013,532,00011,648,62110,446,28312,365,97710,367,00212,057,58010,192,82711,440,9259,010,58211,072,6389,153,40010,024,5359,305,83710,245,49110,019,49111,601,66110,311,9547,252,8815,802,7837,078,2964,946,5575,916,3594,403,9925,569,6693,929,2145,271,6443,142,1724,406,3013,288,7054,182,0293,250,0003,546,2104,952,1373,276,7155,079,620
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
25,732,000
0
23,105,000
0
23,085,000
0
20,964,000
0
21,261,000
0
25,556,000
0
30,381,000
30,381,000025,556,000021,261,000020,964,000023,085,000023,105,000025,732,0000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-21,115,000
-21,115,000
-2,364,000
-2,364,000
0
0
0
0
0
0
0
1,219,000
0
0
0
1,195,000
0
0
0
1,354,000
0
0
001,354,0000001,195,0000001,219,0000000000-2,364,000-2,364,000-21,115,000-21,115,0000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
976,000
0
93,000
0
1,228,000
0
75,000
0
1,230,000
0
36,000
0
1,347,000
1,347,000036,00001,230,000075,00001,228,000093,0000976,0000000000000000000000000000000000000000000000
> Total Stockholder Equity
16,372,053
17,039,658
17,014,137
17,455,718
18,139,410
15,043,736
15,822,916
19,038,772
20,305,911
24,730,985
24,916,208
26,560,694
32,369,221
38,387,864
41,077,501
40,027,363
48,202,313
41,674,318
3,102,972
7,111,411
5,142,009
10,106,735
10,495,662
12,902,710
10,138,113
15,831,786
14,767,196
21,668,913
19,640,280
19,716,126
18,303,017
20,943,396
18,850,082
23,534,449
22,816,000
23,801,000
26,441,000
27,152,000
28,625,707
27,525,161
28,076,845
28,139,772
28,400,765
28,059,000
33,476,155
32,747,000
0
31,509,000
0
36,341,000
0
37,814,000
0
24,489,000
0
25,189,000
25,189,000024,489,000037,814,000036,341,000031,509,000032,747,00033,476,15528,059,00028,400,76528,139,77228,076,84527,525,16128,625,70727,152,00026,441,00023,801,00022,816,00023,534,44918,850,08220,943,39618,303,01719,716,12619,640,28021,668,91314,767,19615,831,78610,138,11312,902,71010,495,66210,106,7355,142,0097,111,4113,102,97241,674,31848,202,31340,027,36341,077,50138,387,86432,369,22126,560,69424,916,20824,730,98520,305,91119,038,77215,822,91615,043,73618,139,41017,455,71817,014,13717,039,65816,372,053
   Common Stock
0
98,752
0
96,397
107,239
115,665
118,352
129,241
127,796
140,203
124,737
121,692
0
131,201
0
141,230
0
149,911
147,235
154,470
148,506
170,776
190,182
170,685
168,687
174,768
169,312
179,695
180,424
161,063
171,196
159,728
163,399
157,480
160,000
167,000
160,000
164,000
167,469
161,031
162,635
162,999
160,000
160,000
160,000
160,000
160,000
160,000
160,000
160,000
160,000
160,000
160,000
160,000
25,189,000
25,189,000
25,189,00025,189,000160,000160,000160,000160,000160,000160,000160,000160,000160,000160,000160,000160,000162,999162,635161,031167,469164,000160,000167,000160,000157,480163,399159,728171,196161,063180,424179,695169,312174,768168,687170,685190,182170,776148,506154,470147,235149,9110141,2300131,2010121,692124,737140,203127,796129,241118,352115,665107,23996,397098,7520
   Retained Earnings Total Equity00000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000000000000000000000000000000000000
   Capital Surplus 00000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000-1,044,6920-897,6960-1,723,6570-2,650,593-2,958,605-3,790,747-3,540,735-3,701,939-3,958,873-4,231,186-2,304,290-2,084,5890-2,571,2550
   Other Stockholders Equity 00-9,832,000-9,832,000-9,032,000-9,032,000-9,390,000-9,390,000-8,467,000-8,467,000-7,937,000-7,937,000-7,628,000-7,628,000-7,613,081-7,596,056-7,046,095-7,327,821-6,985,000-6,985,000-7,641,000-7,641,0000000000000000000000000000000000000



Balance Sheet

Currency in CHF. All numbers in thousands.




Cash Flow

Currency in CHF. All numbers in thousands.